Back to results
TerminatedPhase 2

A Phase 2a Study to Investigate REM0046127 in Mild to Moderate Alzheimer's Disease

NCT05478031

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

BRC Amsterdam

Amsterdam, Amsterdam, Netherlands

+2 additional locations

View on ClinicalTrials.gov
A Phase 2a Study to Investigate REM0046127 in Mild to Moderate Alzheimer's Disease — TrialFind